Society guideline links: Peritoneal mesothelioma

Introduction — 

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●Peritoneal Surface Oncology Group International (PSOGI)/European Network for Rare Adult Solid Cancer (EURACAN): Clinical practice guidelines for diagnosis, treatment and follow-up of peritoneal mesothelioma (2021)

●Enhanced Recovery After Surgery (ERAS): Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy (HIPEC) – Part I: Preoperative and intraoperative management (2020)

●ERAS: Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy (HIPEC) – Part II: Postoperative management and special considerations (2020)

Canada

●Cancer Care Ontario (CCO): Guideline on indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery (2019)

United States

●The Chicago consensus on peritoneal surface malignancies – Management of peritoneal mesothelioma (2020)

Europe

●Peritoneal Surface Oncology Group International (PSOGI)/European Network for Rare Adult Solid Cancer (EURACAN): Clinical practice guidelines for diagnosis, treatment and follow-up of peritoneal mesothelioma (2021)